237 related articles for article (PubMed ID: 8355043)
1. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.
Picci P; Rougraff BT; Bacci G; Neff JR; Sangiorgi L; Cazzola A; Baldini N; Ferrari S; Mercuri M; Ruggieri P
J Clin Oncol; 1993 Sep; 11(9):1763-9. PubMed ID: 8355043
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.
Picci P; Böhling T; Bacci G; Ferrari S; Sangiorgi L; Mercuri M; Ruggieri P; Manfrini M; Ferraro A; Casadei R; Benassi MS; Mancini AF; Rosito P; Cazzola A; Barbieri E; Tienghi A; Brach del Prever A; Comandone A; Bacchini P; Bertoni F
J Clin Oncol; 1997 Apr; 15(4):1553-9. PubMed ID: 9193352
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
[TBL] [Abstract][Full Text] [Related]
5. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.
Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM
Tumori; 2014; 100(4):452-8. PubMed ID: 25296596
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
[TBL] [Abstract][Full Text] [Related]
8. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
9. Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone.
van der Woude HJ; Bloem JL; Taminiau AH; Nooy MA; Hogendoorn PC
Skeletal Radiol; 1994 Oct; 23(7):501-7. PubMed ID: 7824975
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S
J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532
[TBL] [Abstract][Full Text] [Related]
13. The role of surgery and resection margins in the treatment of Ewing's sarcoma.
Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
Clin Orthop Relat Res; 2001 Nov; (392):394-9. PubMed ID: 11716413
[TBL] [Abstract][Full Text] [Related]
14. Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma.
Abudu A; Davies AM; Pynsent PB; Mangham DC; Tillman RM; Carter SR; Grimer RJ
J Bone Joint Surg Br; 1999 Mar; 81(2):317-22. PubMed ID: 10204943
[TBL] [Abstract][Full Text] [Related]
15. Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools.
Righi A; Pacheco M; Palmerini E; Carretta E; Gambarotti M; Longhi A; Magagnoli G; Sbaraglia M; Manfrini M; Picci P; Dei Tos AP
Eur J Surg Oncol; 2021 Jul; 47(7):1778-1783. PubMed ID: 33622576
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
[TBL] [Abstract][Full Text] [Related]
17. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
[TBL] [Abstract][Full Text] [Related]
18. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
[TBL] [Abstract][Full Text] [Related]
19. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
[TBL] [Abstract][Full Text] [Related]
20. Surgical indications for Ewing's sarcoma of the pelvis.
Yang RS; Eckardt JJ; Eilber FR; Rosen G; Forscher CA; Dorey FJ; Kelly CM; al-Shaikh R
Cancer; 1995 Oct; 76(8):1388-97. PubMed ID: 8620413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
